GLA bypasses the impaired delta-6 desaturase step: dietary linoleic acid → (delta-6 desaturase) → GLA → DGLA. DGLA then has three fates: (1) COX-1 converts DGLA to PGE1 — ANTI-inflammatory prostaglandin (vasodilatory, anti-aggregatory, immunomodulatory); (2) 15-LOX converts DGLA to 15-HETrE — blocks LTB4 production (anti-inflammatory); (3) delta-5 desaturase converts DGLA to arachidonic acid (pro-inflammatory) — BUT this step is blocked by EPA (omega-3). So: GLA + EPA = maximum anti-inflammatory effect (GLA produces DGLA→PGE1, while EPA blocks DGLA→AA conversion and competes with AA for COX/LOX).
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.